Here are five notes:
1. The company’s sentiment was 1.19 in the fourth quarter of 2015.
2. NuVasive has a market cap of $3.01 billion and a P/E ratio of 124.97.
3. During the last trading session, NuVasive shares hit $59.97 per share, up 0.42 percent.
4. Since November, the company’s shares have increased 14.85 percent.
5. NuVasive shares have outperformed the S&P500 by 14.38 percent.
More articles on devices:
Bioventus files for $150M IPO: 5 points
United Orthopedic Corp. teams up with Dr. Freddy Achecar to offer TKR, THR to underserved in China: 4 notes
Prosidyan, MO-SCI collaborate on new orthopedic technology — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
